CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same
申请人:PAYNE Gillian
公开号:US20090099336A1
公开(公告)日:2009-04-16
Cytotoxic conjugates comprising a cell binding agent and a cytotoxic agent, therapeutic compositions comprising the conjugate, methods for using the conjugates in the inhibition of cell growth and the treatment of disease, and a kit comprising the cytotoxic conjugate are disclosed are all embodiments of the invention. In particular, the cell binding agent is a monoclonal antibody, and epitope-binding fragments thereof, that recognizes and binds the CA6 glycotope. The present invention is also directed to humanized or resurfaced versions of DS6, an anti-CA6 murine monoclonal antibody, and epitope-binding fragments thereof.
US8153765B2
申请人:——
公开号:US8153765B2
公开(公告)日:2012-04-10
US8987424B2
申请人:——
公开号:US8987424B2
公开(公告)日:2015-03-24
[EN] CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS<br/>[FR] CONJUGUÉS COMPRENANT DES AGENTS DE LIAISON CELLULAIRE (CBA) ET DES AGENTS CYTOTOXIQUES
申请人:IMMUNOGEN INC
公开号:WO2014134483A2
公开(公告)日:2014-09-04
The invention provides linker compounds and cytotoxic compounds that are useful for forming a CBA-drug conjugates, and conjugates so formed. Such conjugates and/or cytotoxic compounds may be effective for treating a range of diseases, such as cancer, with a relatively high activity at a relatively low, non-toxic dose.